dabigatran has been researched along with Neointima in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, JQ; Ji, JJ; Ma, GS; Qian, LL; Wu, YP; Yao, YY | 1 |
| Aydin Ozturk, P; Ozturk, U; Yilmaz, T | 1 |
2 other study(ies) available for dabigatran and Neointima
| Article | Year |
|---|---|
Protective role of serpina3c as a novel thrombin inhibitor against atherosclerosis in mice.
Topics: Animals; Antithrombins; Aorta; Apolipoproteins E; Atherosclerosis; Cells, Cultured; Dabigatran; Diet, High-Fat; Male; Mice, Inbred C57BL; Mice, Knockout; Neointima; Plaque, Atherosclerotic; Serpins; Signal Transduction; Thrombin | 2021 |
Effects of Bemiparin Sodium Versus Dabigatran Etexilate After Anastomosis in Rat Carotid Arteries on the Development of Neointima and Thrombolytic Efficacy.
Topics: Animals; Anticoagulants; Antithrombins; Carotid Arteries; Cerebral Revascularization; Dabigatran; Heparin, Low-Molecular-Weight; Neointima; Rats; Rats, Sprague-Dawley; Thrombosis | 2019 |